company background image
LUDG logo

Ludwig Enterprises OTCPK:LUDG Stock Report

Last Price

US$0.08

Market Cap

US$12.9m

7D

-11.1%

1Y

-63.6%

Updated

18 May, 2025

Data

Company Financials

Ludwig Enterprises, Inc.

OTCPK:LUDG Stock Report

Market Cap: US$12.9m

LUDG Stock Overview

Operates as a genomic technology and health related company in the United States. More details

LUDG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Ludwig Enterprises, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ludwig Enterprises
Historical stock prices
Current Share PriceUS$0.08
52 Week HighUS$0.39
52 Week LowUS$0.068
Beta2.78
1 Month Change-6.98%
3 Month Change-46.67%
1 Year Change-63.64%
3 Year Change284.62%
5 Year Change1,059.42%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

LUDGUS BiotechsUS Market
7D-11.1%3.7%5.3%
1Y-63.6%-14.5%11.9%

Return vs Industry: LUDG underperformed the US Biotechs industry which returned -14.5% over the past year.

Return vs Market: LUDG underperformed the US Market which returned 11.9% over the past year.

Price Volatility

Is LUDG's price volatile compared to industry and market?
LUDG volatility
LUDG Average Weekly Movement27.8%
Biotechs Industry Average Movement12.0%
Market Average Movement8.1%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market4.1%

Stable Share Price: LUDG's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: LUDG's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20063Charles Toddwww.ludwigent.com

Ludwig Enterprises, Inc. operates as a genomic technology and health related company in the United States. The company engages in the developing of products that use inflammatory genetic markers to assess the occurrence of inflammation and inflammation related diseases, as well as monitor treatment responses. It also provides Revealia for Life Home Test Kits, that identify the potential to develop chronic inflammatory diseases, such as cancer and heart disease.

Ludwig Enterprises, Inc. Fundamentals Summary

How do Ludwig Enterprises's earnings and revenue compare to its market cap?
LUDG fundamental statistics
Market capUS$12.93m
Earnings (TTM)-US$2.01m
Revenue (TTM)US$207.00

Over9,999x

P/S Ratio

-6.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LUDG income statement (TTM)
RevenueUS$207.00
Cost of RevenueUS$0
Gross ProfitUS$207.00
Other ExpensesUS$2.01m
Earnings-US$2.01m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.012
Gross Margin100.00%
Net Profit Margin-973,085.02%
Debt/Equity Ratio-76.5%

How did LUDG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/18 15:07
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ludwig Enterprises, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.